True Wealth Design’s INmune Bio INMB Stock Holding History

True Wealth Design’s Portfolio INMB Stock Details INMB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-291	Closed	-$475	–	2679
2026 Q2	$475	Buy	291 +280	+2,545%	+$387	﹤0.01%	2218
2026 Q1	$13	Buy	+11	New	+$16	﹤0.01%	2660

Other funds holding INMB

AHL

Abel Hall LLC Baton Rouge, Louisiana $556M AUM 43.18% 1-Year Est. Return

BFA

Bill Few Associates Pittsburgh, Pennsylvania $485M AUM 17.8% 1-Year Est. Return

Davenport & Co Richmond, Virginia $19.9B AUM 12.67% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return

True Wealth Design's INMB Position: Q3 2026 in Review

True Wealth Design sold out of INmune Bio (INMB) in Q3 2026, closing a stake of 291 shares — an estimated $475 sold.

True Wealth Design first reported a position in INMB in Q1 2026 and held it in 2 quarters. The position peaked at $475 in Q2 2026. 6 funds tracked by Wall St. Rank hold INMB as of Q3 2026.

True Wealth Design reported no remaining INmune Bio position as of Q3 2026 after selling out during the quarter.
True Wealth Design sold 291 INmune Bio shares in Q3 2026, an estimated $475.
True Wealth Design first reported a position in INmune Bio in Q1 2026 and held it in 2 quarters.
True Wealth Design's INmune Bio position peaked at $475 in Q2 2026.
6 funds tracked by Wall St. Rank held INmune Bio as of Q3 2026.

Based on True Wealth Design's 13F filing for Q3 2026, filed 13 Oct 2026.